HUTCHMED (China) Limited
HUTCHMED (China) Limited (HCM) Stock Overview
Explore HUTCHMED (China) Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.5B
P/E Ratio
5.21
EPS (TTM)
$2.65
ROE
0.42%
HCM Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of HUTCHMED (China) Limited (HCM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 45.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $17.57.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.21 and a market capitalization of 2.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.